Pharmacologically induced alterations of cortical and subcortical evoked potentials compared with physiological changes during the awake-sleep cycle in cats.
D000661:Amphetamine / Q000494:pharmacology; D000777:Anesthetics / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001303:Auditory Cortex / Q000502:physiology; D002110:Caffeine / Q000494:pharmacology; D002415:Cats; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology*; D002698:Chloralose / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003201:Computers; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects*; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology*; D007099:Imipramine / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010546:Perphenazine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D012890:Sleep; D013788:Thalamus / Q000187:drug effects / Q000502:physiology*; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014793:Visual Cortex / Q000502:physiology; D014851:Wakefulness
D000777:Anesthetics; D000697:Central Nervous System Stimulants; D014149:Tranquilizing Agents; D002698:Chloralose; D002110:Caffeine; D004295:Dihydroxyphenylalanine; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D010830:Physostigmine; D000661:Amphetamine; D010546:Perphenazine; D010424:Pentobarbital; D007099:Imipramine; D002746:Chlorpromazine